Jump to main content
Jump to site search


Near-Infrared-Emitting Heteroleptic Cationic Iridium Complexes Derived from 2,3-Diphenylbenzo[g]quinoxaline as In Vitro Theranostic Photodynamic Therapy Agents

Abstract

Five heteroleptic cationic iridium complexes with -expansive cyclometalating 2,3-diphenylbenzo[g]quinoxaline (dpbq) ligand (C^N ligand) and different diimine ligands (N^N ligands) (i.e. 2,2-bipyridine (bpy, 1), phenanthroline (phen, 2), 2-(2-pyridinyl)quinoline (pqu, 3), 2,2-bisquinoline (bpu, 4), 2-(quinolin-2-yl)quinoxaline (quqo, 5) were synthesized and characterized. The lowest-energy singlet electronic transitions (S1 states) were mainly dpbq ligand-centred 1ILCT (intraligand charge transfer) / 1MLCT (metal to ligand charge transfer) transitions mixed with some 1* transitions for complexes 1-4 with increased contribution from 1LLCT (ligand to ligand charge transfer) in 3 and 4. For complex 5, the S1 state was switched to the 1LLCT/1MLCT transitions. All five complexes displayed weak near-infrared (NIR) phosphorescence, with emission maximal output spanning 700-1400 nm and quantum yields being on the order of 10-3. The triplet state absorption of 1-4 all resembled that of the [Ir(dpbq)2Cl]2 dimer with lifetimes of ca. 400 ns, while the TA spectrum of 5 possessed the characteristics of both the quqo ligand and the [Ir(dpbq)2Cl]2 dimer with a bi-exponential decay of ca. 5 s and 400 ns. While the photophysics of these complexes differ slightly, their theranostic photodynamic therapy (PDT) effects varied drastically. All of the complexes were biologically active toward melanoma cells. Complexes 2 and 3 were the most cytotoxic, with 230-340 nM activity and selectivity factors for melanoma cells over normal skin fibroblasts of 34 to 40 fold. Complexes 2, 3, and 5 became very potent cytotoxins with light activation, with EC50 values of as low as 12-18 nM. This potent nanomolar light-triggered activity combined with a lower dark toxicity resulted in 5 having a phototherapeutic margin of almost 275. The bpy coligand led to the least amount of dark toxicity of 1, while phen and pqu produced cytotoxic but selective complexes 2 and 3. The quqo coligand produced the most potent complex 5 for in vitro PDT, both in terms of photocytotoxicity and phototherapeutic index (PI). All Ir(III) complexes exhibited very bright NIR phosphorescence in melanoma cells. The wide range of cytotoxicity and photocytotoxicity effects within a relatively small class of complexes highlights the importance of the identity of the coligand on the biological activity of the-expansive biscyclometalated Ir(III) complexes, and their bright NIR emission in live cells demonstrates their potential as theranostic PDT agents.

Back to tab navigation
Please wait while Download options loads

Supplementary files

Publication details

The article was received on 13 Mar 2017, accepted on 19 May 2017 and first published on 19 May 2017


Article type: Paper
DOI: 10.1039/C7DT00913E
Citation: Dalton Trans., 2017, Accepted Manuscript
  •   Request permissions

    Near-Infrared-Emitting Heteroleptic Cationic Iridium Complexes Derived from 2,3-Diphenylbenzo[g]quinoxaline as In Vitro Theranostic Photodynamic Therapy Agents

    L. Wang, H. Yin, P. Cui, M. Hetu, C. Wang, S. Monro, R. D. Schaller, C. G. Cameron, B. Liu, S. Kilina, S. A. McFarland and W. Sun, Dalton Trans., 2017, Accepted Manuscript , DOI: 10.1039/C7DT00913E

Search articles by author